Document is current
Any future updates will be listed below
-
Authors
Ekhtiari, Hamed https://orcid.org/0000-0001-6902-8798
Zare-Bidoky, Mehran https://orcid.org/0000-0003-2572-8498
Sangchooli, Arshiya
Janes, Amy C.
Kaufman, Marc J.
Oliver, Jason A.
Prisciandaro, James J.
Wüstenberg, Torsten
Anton, Raymond F.
Bach, Patrick
Baldacchino, Alex
Beck, Anne
Bjork, James M.
Brewer, Judson
Childress, Anna Rose
Claus, Eric D.
Courtney, Kelly E.
Ebrahimi, Mohsen https://orcid.org/0000-0002-9197-3750
Filbey, Francesca M.
Ghahremani, Dara G.
Azbari, Peyman Ghobadi
Goldstein, Rita Z.
Goudriaan, Anna E.
Grodin, Erica N.
Hamilton, J. Paul
Hanlon, Colleen A.
Hassani-Abharian, Peyman
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Joseph, Jane E.
Kiefer, Falk
Zonoozi, Arash Khojasteh
Kober, Hedy
Kuplicki, Rayus
Li, Qiang
London, Edythe D. https://orcid.org/0000-0003-3577-7808
McClernon, Joseph
Noori, Hamid R.
Owens, Max M.
Paulus, Martin P.
Perini, Irene https://orcid.org/0000-0002-5972-0913
Potenza, Marc https://orcid.org/0000-0002-6323-1354
Potvin, Stéphane
Ray, Lara
Schacht, Joseph P. https://orcid.org/0000-0003-4250-0495
Seo, Dongju
Sinha, Rajita
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Spanagel, Rainer
Steele, Vaughn R.
Stein, Elliot A.
Steins-Loeber, Sabine https://orcid.org/0000-0002-7651-0627
Tapert, Susan F.
Verdejo-Garcia, Antonio https://orcid.org/0000-0001-8874-9339
Vollstädt-Klein, Sabine https://orcid.org/0000-0002-6210-672X
Wetherill, Reagan R. https://orcid.org/0000-0002-1991-6292
Wilson, Stephen J.
Witkiewitz, Katie
Yuan, Kai
Zhang, Xiaochu https://orcid.org/0000-0002-7541-0130
Zilverstand, Anna https://orcid.org/0000-0002-4889-9700
-
Funding
Funding for this research was provided by:
Oklahoma Center for the Advancement of Science and Technology (#HR18-139)
Brain and Behavior Research Foundation (NARSAD Young Investigator Award #27305)
- License Information
-
More Information
Article History
Received: 12 October 2020
Accepted: 21 October 2021
First Online: 4 February 2022
Competing interests
: R.F.A. is chair of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative (ACTIVE Group), which has received support in the past 36 months from the following: Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi and Otsuka. He has been a recent consultant for Allergan, Alkermes, Dicerna, Insys, Laboratorio Pharmaceutico and Life Technologies and has received grant funding from Laboratorio Pharmaceutico. A.C.J. consults for Axial Biotherapeutics. M.P.P. consulted for and advised the Addiction Policy Forum, Game Day Data, AXA, Idorsia and Opiant/Lakelight Therapeutics; received research support from the Mohegan Sun Casino and the National Center for Responsible Gaming (now the International Center for Responsible Gaming); consulted for legal and gambling entities on issues related to impulse-control and addictive disorders; has given academic lectures in grand rounds, Continuing Medical Education events and other clinical/scientific venues; and has generated books or chapters for publishers of mental health texts. J.P.S. has consulted for and received grant funding from Laboratorio Farmaceutico CT. The other authors declare no competing interests.
Free to read: This content has been made available to all.
